Approval · Notice of Compliance 32299 · 2023
TOBI: Notice of Compliance 32299
Issued December 6, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32299
- Date
- December 6, 2023
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the product monograph initiated by the sponsor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOBI | Not yet assigned | — |
Medicinal ingredients
- TOBRAMYCIN 300 MG per 5ML